Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-18 Sale | 2024-07-18 4:04 pm | Mural Oncology plc | MURA | Keson-Brookes Maiken See Remarks | 2,157 | $3.41 | $7,355 | 43,850 (Direct) | View |
| 2022-02-01 Sale | 2022-02-01 9:19 pm | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 2,732 | $6.573 | $17,957 | 207,818 (Direct) | View |
| 2021-03-15 Sale | 2021-03-15 8:28 pm | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 25,000 | $20.24 | $505,965 | 225,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-04 5:18 pm | N/A 2034-02-28 | Mural Oncology plc | MURA | Keson-Brookes Maiken See Remarks | 48,000 | $0 | 77,207 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 4:30 pm | N/A 2033-12-13 | Mural Oncology plc | MURA | Keson-Brookes Maiken See Remarks | 83,449 | $0 | 83,449 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 9:19 pm | N/A 2032-01-30 | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 178,250 | $0 | 207,818 (Direct) | View |
| 2022-01-29 Exercise | 2022-02-01 9:19 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 8,075 | $0 | 207,818 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-15 8:28 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 25,000 | $7.7 | 225,000 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-15 8:28 pm | N/A 2029-11-28 | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 25,000 | $0 | 225,000 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 8:27 pm | N/A 2031-01-28 | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 174,800 | $0 | 174,800 (Direct) | View |